| Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 365 (9472), 1687-1717, 2005 | 7988 | 2005 |
| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 6365 | 2005 |
| Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 … Collaborative Group on Hormonal Factors in Breast Cancer The lancet 360 (9328), 187-195, 2002 | 3626* | 2002 |
| Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without … Collaborative Group on Hormonal Factors in Breast Cancer The Lancet 350 (9084), 1047-1059, 1997 | 3226 | 1997 |
| Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ... Lancet 365 (9453), 60-62, 2005 | 3122 | 2005 |
| Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC … A The The Lancet 359 (9324), 2131-2139, 2002 | 2688* | 2002 |
| Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 379 (9814), 432-444, 2012 | 2327 | 2012 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2166 | 1998 |
| Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... Journal of the National cancer Institute 103 (22), 1656-1664, 2011 | 2136 | 2011 |
| A Wilcoxon‐type test for trend J Cuzick Statistics in medicine 4 (1), 87-90, 1985 | 2125 | 1985 |
| Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial WS Atkin, R Edwards, I Kralj-Hans, K Wooldrage, AR Hart, JMA Northover, ... The Lancet 375 (9726), 1624-1633, 2010 | 2111 | 2010 |
| Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women … DLW Kwong, P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, ... The Lancet, 2014 | 2012 | 2014 |
| Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn Annals of oncology 20 (8), 1319-1329, 2009 | 1986 | 2009 |
| A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women EA Joura, AR Giuliano, OE Iversen, C Bouchard, C Mao, J Mehlsen, ... New England Journal of Medicine 372 (8), 711-723, 2015 | 1733 | 2015 |
| Overview of the European and North American studies on HPV testing in primary cervical cancer screening J Cuzick, C Clavel, KU Petry, CJLM Meijer, H Hoyer, S Ratnam, ... International journal of cancer 119 (5), 1095-1101, 2006 | 1543 | 2006 |
| A breast cancer prediction model incorporating familial and personal risk factors J Tyrer, SW Duffy, J Cuzick Statistics in medicine 23 (7), 1111-1130, 2004 | 1477 | 2004 |
| Long-term risk of colorectal cancer after excision of rectosigmoid adenomas WS Atkin, BC Morson, J Cuzick New England Journal of Medicine 326 (10), 658-662, 1992 | 1469 | 1992 |
| Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1341-1352, 2015 | 1404 | 2015 |
| De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ... Annals of Oncology 28 (8), 1700-1712, 2017 | 1329 | 2017 |
| Overview of the main outcomes in breast-cancer prevention trials J Cuzick, T Powles, U Veronesi, J Forbes, R Edwards, S Ashley, P Boyle The Lancet 361 (9354), 296-300, 2003 | 1267 | 2003 |
Anthony Howell, Howell A, Howell TProfessor of Medical Oncology, Manchester Universityبريد إلكتروني تم التحقق منه على picr.man.ac.uk